http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2120881-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a2ff3e8c2e8401e6b90f3ac6ba215e94
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C323-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D279-06
filingDate 1996-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_136fd2d7c5bbaf10d4695a22b62c9deb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bafc6b25afd2491bc0cb762de29abda4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db63aad94343694ad66ad4b27d7e92c0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54603cd29be08eb971aa639b838eff4b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26472040f2827a28713ff2cf42b98884
publicationDate 1998-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-2120881-A1
titleOfInvention ENANTIOMERS OF 5-METHYL-1, 3-TIAZIN-2, 4-DIONA AND ITS USE IN THE INTERMEDIATE SYNTHESIS OF CHIRAL PHARMACES.
abstract Enantiomers of 5-methyl-1,3-thiazine-2,4-dione and their use in the synthesis of chiral drug intermediates. The enantiomers of 5-methyl-1,3-thiazine-2,4-dione (I) are suitable for the synthesis of chiral pharmaceutical active ingredient intermediates. In particular, the S-enantiomer of (I) is useful for the synthesis of S-(-)-3-acetylthio-2-methylpropionic acid (S-AMPA), a precursor to Captopril. These enantiomers can be obtained by stereoselective enzymatic hydrolysis of the racemic 5-methyl-1,3-thiazin-2,4-dione in the presence of a biocatalyst that contains enzymes capable of stereoselectively hydrolyzing said racemic mixture.
priorityDate 1996-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0350811-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5128263-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0369553-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5177006-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6547
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44093
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426494601
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11116172
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493149
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414859283

Total number of triples: 26.